Drug maker Sun Pharmaceutical Industries Ltd on Monday said it is selling off one of its plants in the US for an undisclosed sum.
In a statement, Sun Pharma said as a part of its manufacturing consolidation in the US, one of its wholly-owned subsidiaries has entered into an agreement with Nostrum Laboratories Inc. (Nostrum) for the divestment of the Bryan (Ohio) unit.
"As a part of the agreement, the Sun Pharma subsidiary has divested this unit as a going concern along with the employees and related products to Nostrum," the statement said.
